Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

828
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
828
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

1.0K
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treating tuberculosis without rifampicin: an open dilemma.

Respiratory medicine·2026
Same author

Cerebral and bone multidrug resistant tuberculosis treated with the BPaLM regimen: case report.

Frontiers in pharmacology·2026
Same author

Hospital-Onset Bloodstream Infections: Progressive Shift from Methicillin-Resistant <i>Staphylococcus aureus</i> to Methicillin-Susceptible <i>Staphylococcus aureus</i> over 11 Years.

Journal of clinical medicine·2026
Same author

Extrapolation of oritavancin PK/PD targets to inform therapeutic drug monitoring: a systematic review.

The Journal of antimicrobial chemotherapy·2026
Same author

Biomarker tests of progression from tuberculosis infection to disease: a systematic review.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Tuberculosis in children and young people in a low-incidence country: Shifting trends and the urgent need for targeted vaccination in those at risk.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
Same journal

Advancing lung transplantation: current challenges and future directions.

Current opinion in pulmonary medicine·2026
Same journal

Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.

Current opinion in pulmonary medicine·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

18.4K

Drug-resistant tuberculosis.

Emanuele Pontali1, Alberto Matteelli, Giovanni B Migliori

  • 1Department of Infectious Diseases, Galliera Hospital, Genova, Italy. giovannibattista.migliori@fsm.it

Current Opinion in Pulmonary Medicine
|February 21, 2013
PubMed
Summary
This summary is machine-generated.

Drug-resistant tuberculosis (TB) is rising globally, with new diagnostic tools like Xpert MTB/RIF and novel drugs offering improved treatment outcomes. A public health approach is crucial to prevent further resistance development.

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Related Experiment Videos

Last Updated: May 2, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

18.4K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Area of Science:

  • Infectious Diseases
  • Public Health
  • Microbiology

Background:

  • Drug-resistant tuberculosis (TB) presents a growing global health challenge.
  • Multidrug-resistant TB (MDR-TB) prevalence is increasing, particularly in Eastern Europe.
  • Traditional TB diagnostic methods are being surpassed by newer technologies.

Purpose of the Study:

  • To review recent evidence on the epidemiology of drug-resistant TB.
  • To discuss advancements in the diagnosis of drug-resistant TB.
  • To explore emerging treatment strategies for multidrug-resistant TB.

Main Methods:

  • Literature review of recent studies on TB drug resistance.
  • Analysis of epidemiological data on MDR-TB prevalence.
  • Evaluation of new diagnostic and therapeutic agents for TB.

Main Results:

  • Rising prevalence of drug resistance, with record MDR-TB rates in some regions.
  • Emergence of advanced diagnostic tools, notably Xpert MTB/RIF.
  • Availability of new anti-TB drugs (delamanid, bedaquiline, PA-824) offering hope for improved treatment success.

Conclusions:

  • Innovative diagnostics are revolutionizing TB detection, moving beyond traditional methods.
  • New anti-TB drugs, used in novel regimens, are improving cure rates for MDR-TB.
  • Widespread use of new drugs requires a robust public health strategy to combat further resistance.